ProSomnus Inc. is a leading provider of oral appliances for the treatment of obstructive sleep apnea. With their innovative technology and commitment to patient comfort, they are revolutionizing the way sleep disorders are managed. Their common stock offers investors an opportunity to participate in this rapidly growing market.
